NC
LFCR icon

Northpointe Capital’s Lifecore Biomedical LFCR Stock Holding History

Northpointe Capital’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-219,690
Closed -$2.6M – 128
2018
Q4 		$2.6M Sell
219,690
-100,987
-31% -$1.39M 0.59% 72
2018
Q3 		$4.62M Buy
320,677
+123,111
+62% +$1.7M 0.67% 50
2018
Q2 		$2.94M Buy
+197,566
New +$2.75M 0.39% 115
2013
Q4 		– Sell
-348,658
Closed -$4.25M – 247
2013
Q3 		$4.25M Buy
348,658
+187,608
+116% +$2.62M 0.5% 62
2013
Q2 		$2.13M Buy
+161,050
New +$2.23M 0.25% 100

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Northpointe Capital's LFCR Position: Q1 2019 in Review

Northpointe Capital sold out of Lifecore Biomedical (LFCR) in Q1 2019, closing a stake of 219,690 shares — an estimated $2.6M sold.

Northpointe Capital first reported a position in LFCR in Q2 2013 and held it in 5 quarters. The position peaked at $4.62M in Q3 2018. 91 funds tracked by Wall St. Rank hold LFCR as of Q1 2019.

  • Northpointe Capital reported no remaining Lifecore Biomedical position as of Q1 2019 after selling out during the quarter.
  • Northpointe Capital sold 219,690 Lifecore Biomedical shares in Q1 2019, an estimated $2.6M.
  • Northpointe Capital first reported a position in Lifecore Biomedical in Q2 2013 and held it in 5 quarters.
  • Northpointe Capital's Lifecore Biomedical position peaked at $4.62M in Q3 2018.
  • 91 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2019.

Based on Northpointe Capital's 13F filing for Q1 2019, filed 17 Apr 2019.